<DOC>
	<DOCNO>NCT02894606</DOCNO>
	<brief_summary>The investigator expect good characterise B cell subpopulation functional property early graft , analyse effect induction therapy ( thymoglobulin versus basiliximab ) B cell , compare B cell profile obtain previous study patient chronic Antibody Mediated Rejection ( cAMR )</brief_summary>
	<brief_title>Influence Thymoglobuline Phenotypic Functional Profiles B Lymphocytes Renal Transplant Recipients</brief_title>
	<detailed_description />
	<mesh_term>Basiliximab</mesh_term>
	<mesh_term>Antibodies , Monoclonal</mesh_term>
	<criteria>Age &gt; 18 year old Recipient renal allograft Patient receive either basiliximab thymoglobulin induction therapy renal transplant Patient present low immunologic risk Patient oppose ( ) study participation Patient participate clinical trial</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2016</verification_date>
	<keyword>Kidney Transplant</keyword>
	<keyword>Immunology</keyword>
</DOC>